Umbilical cord blood cell transplantation after brain ischemia-From recovery of function to cellular mechanisms

Annals of Anatomy

Volumn 193, Issue 4, 2011, Pages 371-379

  Rosenkranz, Katja ^a   Meier, Carola ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Brain damage; Human umbilical cord blood; Hypoxia; Ischemia; Stem cells; Transplantation

Indexed keywords

ALTEPLASE; AMLODIPINE; CILNIDIPINE; NEUROTROPHIC FACTOR;

ANGIOGENESIS; ARTICLE; ASTROCYTOSIS; BLOOD CLOT LYSIS; BRAIN CIRCULATION; BRAIN DAMAGE; BRAIN ISCHEMIA; CELL MATURATION; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE MODEL; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNE SYSTEM; INFLAMMATION; MOLECULAR MECHANICS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN SECRETION; REGENERATION;

ANIMALIA;

EID: 79960259816     PISSN: 09409602     EISSN: 16180402     Source Type: Journal    
DOI: 10.1016/j.aanat.2011.03.005     Document Type: Article

References (111)

1. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105(4):1815-1822.
2. Alvarez-Diaz A., Hilario E., de Cerio F.G., Valls-i-Soler A., Alvarez-Diaz F.J. Hypoxic-ischemic injury in the immature brain - key vascular and cellular players. Neonatology 2007, 92(4):227-235.
3. Baal N., Reisinger K., Jahr H., Bohle R.M., Liang O., Munstedt K., Rao C.V., Preissner K.T., Zygmunt M.T. Expression of transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood. Thrombosis and Haemostasis 2004, 92(4):767-775.
4. Bacigaluppi M., Comi G., Hermann D.M. Animal models of ischemic stroke. Part two: modeling cerebral ischemia. The Open Neurology Journal 2010, 4:34-38.
5. Barone F.C., Arvin B., White R.F., Miller A., Webb C.L., Willette R.N., Lysko P.G., Feuerstein G.Z. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke: A Journal of Cerebral Circulation 1997, 28(6):1233-1244.
6. Berger R., Garnier Y. Perinatal brain injury. Journal of Perinatal Medicine 2000, 28(4):261-285.
7. Berger R., Middelanis J., Vaihinger H.M., Mies G., Wilken B., Jensen A. Creatine protects the immature brain from hypoxic-ischemic injury. Journal of the Society for Gynecologic Investigation 2004, 11(1):9-15.
8. Bicknese A.R., Goodwin H.S., Quinn C.O., Henderson V.C., Chien S.N., Wall D.A. Human umbilical cord blood cells can be induced to express markers for neurons and glia. Cell Transplantation 2002, 11(3):261-264.
9. Bona E., Aden U., Gilland E., Fredholm B.B., Hagberg H. Neonatal cerebral hypoxia-ischemia: the effect of adenosine receptor antagonists. Neuropharmacology 1997, 36(9):1327-1338.
10. Borlongan C.V., Hadman M., Sanberg C.D., Sanberg P.R. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke: A Journal of Cerebral Circulation 2004, 35(10):2385-2389.
11. Bracci R., Buonocore G. Chorioamnionitis: a risk factor for fetal and neonatal morbidity. Biology of the Neonate 2003, 83(2):85-96.
12. Busto R., Dietrich W.D., Globus M.Y., Valdes I., Scheinberg P., Ginsberg M.D. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. Journal of Cerebral Blood Flow and Metabolism 1987, 7(6):729-738.
13. Buzanska L., Machaj E.K., Zablocka B., Pojda Z., Domanska-Janik K. Human cord blood-derived cells attain neuronal and glial features in vitro. Journal of Cell Science 2002, 115(10):2131-2138.
14. Chang Y.C., Shyu W.C., Lin S.Z., Li H. Regenerative therapy for stroke. Cell Transplantation 2007, 16(2):171-181.
15. Chen J., Sanberg P.R., Li Y., Wang L., Lu M., Willing A.E., Sanchez-Ramos J., Chopp M. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke: A Journal of Cerebral Circulation 2001, 32(11):2682-2688.
16. Chung D.J., Choi C.B., Lee S.H., Kang E.H., Lee J.H., Hwang S.H., Han H., Lee J.H., Choe B.Y., Lee S.Y., Kim H.Y. Intraarterially delivered human umbilical cord blood-derived mesenchymal stem cells in canine cerebral ischemia. Journal of Neuroscience Research 2009, 87(16):3554-3567.
17. Ding D.C., Shyu W.C., Chiang M.F., Lin S.Z., Chang Y.C., Wang H.J., Su C.Y., Li H. Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiology of Disease 2007, 27(3):339-353.
18. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends in Neurosciences 1999, 22(9):391-397.
19. El-Badri N.S., Hakki A., Saporta S., Liang X., Madhusodanan S., Willing A.E., Sanberg C.D., Sanberg P.R. Cord blood mesenchymal stem cells: potential use in neurological disorders. Stem Cells and Development 2006, 15(4):497-506.
20. Elijovich L., Chong J.Y. Current and future use of intravenous thrombolysis for acute ischemic stroke. Current Atherosclerosis Reports 2010, 12(5):316-321.
21. Emerich D.F., Dean R.L., Bartus R.T. The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct?. Experimental Neurology 2002, 173(1):168-181.
22. Fruchtman S.M., Hurlet A., Dracker R., Isola L., Goldman B., Schneider B.L., Emre S. The successful treatment of severe aplastic anemia with autologous cord blood transplantation. Biology of Blood and Marrow Transplantation 2004, 10(11):741-742.
23. Garbuzova-Davis S., Willing A.E., Zigova T., Saporta S., Justen E.B., Lane J.C., Hudson J.E., Chen N., Davis C.D., Sanberg P.R. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. Journal of Hematotherapy & Stem Cell Research 2003, 12(3):255-270.
24. Garcia J.H., Liu K.F., Yoshida Y., Lian J., Chen S., del Zoppo G.J. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). The American Journal of Pathology 1994, 144(1):188-199.
25. Gluckman E., Broxmeyer H.A., Auerbach A.D., Friedman H.S., Douglas G.W., Devergie A., Esperou H., Thierry D., Socie G., Lehn P., et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. The New England Journal of Medicine 1989, 321(17):1174-1178.
26. Gluckman P.D., Gunn A.J., Wyatt J.S. Hypothermia for neonates with hypoxic-ischemic encephalopathy. The New England Journal of Medicine 2006, 354(15):1643-1645. author reply 1643-1645.
27. Goodwin H.S., Bicknese A.R., Chien S.N., Bogucki B.D., Quinn C.O., Wall D.A. Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biology of Blood and Marrow Transplantation 2001, 7(11):581-588.
28. Green E.J., Dietrich W.D., van Dijk F., Busto R., Markgraf C.G., McCabe P.M., Ginsberg M.D., Schneiderman N. Protective effects of brain hypothermia on behavior and histopathology following global cerebral ischemia in rats. Brain Research 1992, 580(1-2):197-204.
29. Hagberg H., Bona E., Gilland E., Puka-Sundvall M. Hypoxia-ischaemia model in the 7-day-old rat: possibilities and shortcomings. Acta Paediatrica Suppl 1997, 422:85-88.
30. Hagberg H., Mallard C. Antenatal brain injury: aetiology and possibilities of prevention. Seminars in Neonatology 2000, 5(1):41-51.
31. Hall A.A., Guyer A.G., Leonardo C.C., Ajmo C.T., Collier L.A., Willing A.E., Pennypacker K.R. Human umbilical cord blood cells directly suppress ischemic oligodendrocyte cell death. Journal of Neuroscience Research 2009, 87(2):333-341.
32. Hall A.A., Leonardo C.C., Collier L.A., Rowe D.D., Willing A.E., Pennypacker K.R. Delayed treatments for stroke influence neuronal death in rat organotypic slice cultures subjected to oxygen glucose deprivation. Neuroscience 2009, 164(2):470-477.
33. Hau S., Reich D.M., Scholz M., Naumann W., Emmrich F., Kamprad M., Boltze J. Evidence for neuroprotective properties of human umbilical cord blood cells after neuronal hypoxia in vitro. BMC Neuroscience 2008, 9:30.
34. Howells D.W., Porritt M.J., Rewell S.S., O'Collins V., Sena E.S., van der Worp H.B., Traystman R.J., Macleod M.R. Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 2010, 30(8):1412-1431.
35. Hu C.H., Wu G.F., Wang X.Q., Yang Y.H., Du Z.M., He X.H., Xiang P. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction. Chinese Medical Journal 2006, 119(18):1499-1506.
36. Iadecola C., Salkowski C.A., Zhang F., Aber T., Nagayama M., Vogel S.N., Ross M.E. The transcription factor interferon regulatory factor 1 is expressed after cerebral ischemia and contributes to ischemic brain injury. The Journal of Experimental Medicine 1999, 189(4):719-727.
37. Ivacko J.A., Sun R., Silverstein F.S. Hypoxic-ischemic brain injury induces an acute microglial reaction in perinatal rats. Pediatric Research 1996, 39(1):39-47.
38. Jacobs S., Hunt R., Tarnow-Mordi W., Inder T., Davis P. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database of Systematic Reviews 2007, (4):CD003311. (Online).
39. Jager M., Degistirici O., Knipper A., Fischer J., Sager M., Krauspe R. Bone healing and migration of cord blood-derived stem cells into a critical size femoral defect after xenotransplantation. Journal of Bone and Mineral Research 2007, 22(8):1224-1233.
40. Jensen A., Berger R. Fetal circulatory responses to oxygen lack. Journal of Developmental Physiology 1991, 16(4):181-207.
41. Jiang L., Saporta S., Chen N., Sanberg C.D., Sanberg P., Willing A. The effect of human umbilical cord blood cells on survival and cytokine production by post-ischemic astrocytes in vitro. Stem Cell Reviews 2010, 6(4):523-531.
42. Jiang L., Womble T., Saporta S., Chen N., Sanberg C.D., Sanberg P.R., Willing A.E. Human umbilical cord blood cells decrease microglial survival in vitro. Stem Cells and Development 2010, 19(2):221-228.
43. Kelly P., Kurtzberg J., Vichinsky E., Lubin B. Umbilical cord blood stem cells: application for the treatment of patients with hemoglobinopathies. The Journal of Pediatrics 1997, 130(5):695-703.
44. Kim B.O., Tian H., Prasongsukarn K., Wu J., Angoulvant D., Wnendt S., Muhs A., Spitkovsky D., Li R.K. Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 2005, 112(9 Suppl.):I96-104.
45. Kogler G., Sensken S., Airey J.A., Trapp T., Muschen M., Feldhahn N., Liedtke S., Sorg R.V., Fischer J., Rosenbaum C., Greschat S., Knipper A., Bender J., Degistirici O., Gao J., Caplan A.I., Colletti E.J., Almeida-Porada G., Muller H.W., Zanjani E., Wernet P. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. The Journal of Experimental Medicine 2004, 200(2):123-135.
46. Kosmacheva S.M., Volk M.V., Yeustratenka T.A., Severin I.N., Potapnev M.P. In vitro growth of human umbilical blood mesenchymal stem cells and their differentiation into chondrocytes and osteoblasts. Bulletin of Experimental Biology and Medicine 2008, 145(1):141-145.
47. Krupinski J., Kaluza J., Kumar P., Kumar S., Wang J.M. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke: A Journal of Cerebral Circulation 1994, 25(9):1794-1798.
48. Kucia M., Halasa M., Wysoczynski M., Baskiewicz-Masiuk M., Moldenhawer S., Zuba-Surma E., Czajka R., Wojakowski W., Machalinski B., Ratajczak M.Z. Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia 2007, 21(2):297-303.
49. Ladeby R., Wirenfeldt M., Garcia-Ovejero D., Fenger C., Dissing-Olesen L., Dalmau I., Finsen B. Microglial cell population dynamics in the injured adult central nervous system. Brain Research. Brain Research Reviews 2005, 48(2):196-206.
50. Lapchak P.A. A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?. Expert Opinion on Pharmacotherapy 2010, 11(10):1753-1763.
51. Leeb C., Jurga M., McGuckin C., Moriggl R., Kenner L. Promising new sources for pluripotent stem cells. Stem Cell Reviews 2010, 6(1):15-26.
52. Levine S. Anoxic-ischemic encephalopathy in rats. The American Journal of Pathology 1960, 36:1-17.
53. Li Y., Chen J., Zhang C.L., Wang L., Lu D., Katakowski M., Gao Q., Shen L.H., Zhang J., Lu M., Chopp M. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 2005, 49(3):407-417.
54. Liu H.Y., Zhang Q.J., Li H.J., Han Z.C. Effect of intracranial transplantation of CD34+ cells derived from human umbilical cord blood in rats with cerebral ischemia. Chinese Medical Journal 2006, 119(20):1744-1748.
55. Locatelli F., Rocha V., Reed W., Bernaudin F., Ertem M., Grafakos S., Brichard B., Li X., Nagler A., Giorgiani G., Haut P.R., Brochstein J.A., Nugent D.J., Blatt J., Woodard P., Kurtzberg J., Rubin C.M., Miniero R., Lutz P., Raja T., Roberts I., Will A.M., Yaniv I., Vermylen C., Tannoia N., Garnier F., Ionescu I., Walters M.C., Lubin B.H., Gluckman E. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003, 101(6):2137-2143.
56. Lu D., Sanberg P.R., Mahmood A., Li Y., Wang L., Sanchez-Ramos J., Chopp M. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplantation 2002, 11(3):275-281.
57. Lukic-Panin V., Kamiya T., Zhang H., Hayashi T., Tsuchiya A., Sehara Y., Deguchi K., Yamashita T., Abe K. Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats. Brain Research 2007, 1176:143-150.
58. Majka M., Janowska-Wieczorek A., Ratajczak J., Ehrenman K., Pietrzkowski Z., Kowalska M.A., Gewirtz A.M., Emerson S.G., Ratajczak M.Z. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 2001, 97(10):3075-3085.
59. Makinen S., Kekarainen T., Nystedt J., Liimatainen T., Huhtala T., Narvanen A., Laine J., Jolkkonen J. Human umbilical cord blood cells do not improve sensorimotor or cognitive outcome following transient middle cerebral artery occlusion in rats. Brain Research 2006, 1123(1):207-215.
60. Martin H.G., Wang Y.T. Blocking the deadly effects of the NMDA receptor in stroke. Cell 2010, 140(2):174-176.
61. Martin R.L., Lloyd H.G., Cowan A.I. The early events of oxygen and glucose deprivation: setting the scene for neuronal death?. Trends in Neurosciences 1994, 17(6):251-257.
62. Meier C., Middelanis J., Wasielewski B., Neuhoff S., Roth-Haerer A., Gantert M., Dinse H.R., Dermietzel R., Jensen A. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatric Research 2006, 59(2):244-249.
63. Neuhoff S., Moers J., Rieks M., Grunwald T., Jensen A., Dermietzel R., Meier C. Proliferation, differentiation, and cytokine secretion of human umbilical cord blood-derived mononuclear cells in vitro. Experimental Hematology 2007, 35(7):1119-1131.
64. Newcomb J.D., Ajmo C.T., Sanberg C.D., Sanberg P.R., Pennypacker K.R., Willing A.E. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplantation 2006, 15(3):213-223.
65. Newman M.B., Willing A.E., Manresa J.J., Sanberg C.D., Sanberg P.R. Cytokines produced by cultured human umbilical cord blood (HUCB) cells: implications for brain repair. Experimental Neurology 2006, 199(1):201-208.
66. O'Neill L.A., Kaltschmidt C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends in Neurosciences 1997, 20(6):252-258.
67. Ohno M., Aotani H., Shimada M. Glial responses to hypoxic/ischemic encephalopathy in neonatal rat cerebrum. Brain Research. Developmental Brain Research 1995, 84(2):294-298.
68. Palmer C. Hypoxic-ischemic encephalopathy. Therapeutic approaches against microvascular injury, and role of neutrophils, PAF, and free radicals. Clinics in Perinatology 1995, 22(2):481-517.
69. Pimentel-Coelho P.M., Magalhaes E.S., Lopes L.M., Deazevedo L.C., Santiago M.F., Mendez-Otero R. Human cord blood transplantation in a neonatal rat model of hypoxic-ischemic brain damage: functional outcome related to neuroprotection in the striatum. Stem Cells and Development 2010, 19(3):351-358.
70. Planas A.M., Soriano M.A., Berruezo M., Justicia C., Estrada A., Pitarch S., Ferrer I. Induction of Stat3, a signal transducer and transcription factor, in reactive microglia following transient focal cerebral ischaemia. The European Journal of Neuroscience 1996, 8(12):2612-2618.
71. Rice J.E., Vannucci R.C., Brierley J.B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Annals of Neurolology 1981, 9(2):131-141.
72. Rizvanov A.A., Kiyasov A.P., Gaziziov I.M., Yilmaz T.S., Kaligin M.S., Andreeva D.I., Shafigullina A.K., Guseva D.S., Kiselev S.L., Matin K., Palotas A., Islamov R.R. Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis-a novel approach in stem cell therapy. Neurochemistry International 2008, 53(6-8):389-394.
73. Rocha V., Cornish J., Sievers E.L., Filipovich A., Locatelli F., Peters C., Remberger M., Michel G., Arcese W., Dallorso S., Tiedemann K., Busca A., Chan K.W., Kato S., Ortega J., Vowels M., Zander A., Souillet G., Oakill A., Woolfrey A., Pay A.L., Green A., Garnier F., Ionescu I., Wernet P., Sirchia G., Rubinstein P., Chevret S., Gluckman E. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001, 97(10):2962-2971.
74. Rosenkranz K., Kumbruch S., Lebermann K., Marschner K., Jensen A., Dermietzel R., Meier C. The chemokine SDF-1/CXCL12 contributes to the 'homing' of umbilical cord blood cells to a hypoxic-ischemic lesion in the rat brain. Journal of Neuroscience Research 2010, 88(6):1223-1233.
75. Rothwell N., Allan S., Toulmond S. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. The Journal of Clinical Investigation 1997, 100(11):2648-2652.
76. Ruscher K., Isaev N., Trendelenburg G., Weih M., Iurato L., Meisel A., Dirnagl U. Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons. Neuroscience Letters 1998, 254(2):117-120.
77. Sanchez-Ramos J.R., Song S., Kamath S.G., Zigova T., Willing A., Cardozo-Pelaez F., Stedeford T., Chopp M., Sanberg P.R. Expression of neural markers in human umbilical cord blood. Experimental Neurology 2001, 171(1):109-115.
78. Schurr A. Neuroprotection against ischemic/hypoxic brain damage: blockers of ionotropic glutamate receptor and voltage sensitive calcium channels. Current Drug Targets 2004, 5(7):603-618.
79. Sensebe L., Bourin P. Mesenchymal stem cells for therapeutic purposes. Transplantation 2009, 87(9 Suppl.):S49-53.
80. Sensken S., Waclawczyk S., Knaupp A.S., Trapp T., Enczmann J., Wernet P., Kogler G. In vitro differentiation of human cord blood-derived unrestricted somatic stem cells towards an endodermal pathway. Cytotherapy 2007, 9(4):362-378.
81. Slemmer J.E., Shacka J.J., Sweeney M.I., Weber J.T. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Current Medicinal Chemistry 2008, 15(4):404-414.
82. Stanevsky A., Shimoni A., Yerushalmi R., Nagler A. Double umbilical cord blood transplant: more than a cell dose?. Leukemia & Lymphoma 2010, 51(6):975-982.
83. Streit W.J., Walter S.A., Pennell N.A. Reactive microgliosis. Progress in Neurobiology 1999, 57(6):563-581.
84. Sun W., Buzanska L., Domanska-Janik K., Salvi R.J., Stachowiak M.K. Voltage-sensitive and ligand-gated channels in differentiating neural stem-like cells derived from the nonhematopoietic fraction of human umbilical cord blood. Stem Cells (Dayton, Ohio) 2005, 23(7):931-945.
85. Taguchi A., Soma T., Tanaka H., Kanda T., Nishimura H., Yoshikawa H., Tsukamoto Y., Iso H., Fujimori Y., Stern D.M., Naritomi H., Matsuyama T. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. The Journal of Clinical Investigation 2004, 114(3):330-338.
86. Takahara A., Konda T., Enomoto A., Kondo N. Neuroprotective effects of a dual L/N-type Ca(2+) channel blocker cilnidipine in the rat focal brain ischemia model. Biological & Pharmaceutical Bulletin 2004, 27(9):1388-1391.
87. Trendelenburg G., Dirnagl U. Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 2005, 50(4):307-320.
88. Vannucci S.J., Hagberg H. Hypoxia-ischemia in the immature brain. Jounal of Experimental Biology 2004, 207(Pt 18):3149-3154.
89. Vannucci R.C., Vannucci S.J. Perinatal hypoxic-ischemic brain damage: evolution of an animal model. Developmental Neuroscience 2005, 27(2-4):81-86.
90. Vendrame M., Cassady J., Newcomb J., Butler T., Pennypacker K.R., Zigova T., Sanberg C.D., Sanberg P.R., Willing A.E. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke: A Journal of Cerebral Circulation 2004, 35(10):2390-2395.
91. Vendrame M., Gemma C., de Mesquita D., Collier L., Bickford P.C., Sanberg C.D., Sanberg P.R., Pennypacker K.R., Willing A.E. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells and Development 2005, 14(5):595-604.
92. Volpe J.J. Neurobiology of periventricular leukomalacia in the premature infant. Pediatric Research 2001, 50(5):553-562.
93. Volpe J.J. Perinatal brain injury: from pathogenesis to neuroprotection. Mental Retardation and Developmental Disabilities Research Reviews 2001, 7(1):56-64.
94. Wagner J.E., Gluckman E. Umbilical cord blood transplantation: the first 20 years. Seminars in Hematology 2010, 47(1):3-12.
95. Widmann R., Miyazawa T., Hossmann K.A. Protective effect of hypothermia on hippocampal injury after 30minutes of forebrain ischemia in rats is mediated by postischemic recovery of protein synthesis. Journal of Neurochemistry 1993, 61(1):200-209.
96. Willing A.E., Lixian J., Milliken M., Poulos S., Zigova T., Song S., Hart C., Sanchez-Ramos J., Sanberg P.R. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. Journal of Neuroscience Research 2003, 73(3):296-307.
97. Xia G., Hong X., Chen X., Lan F., Zhang G., Liao L. Intracerebral transplantation of mesenchymal stem cells derived from human umbilical cord blood alleviates hypoxic ischemic brain injury in rat neonates. Journal of Perinatal Medicine 2010, 38(2):215-221.
98. Xiao J., Nan Z., Motooka Y., Low W.C. Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells and Development 2005, 14(6):722-733.
99. Xiong Y., Mahmood A., Chopp M. Angiogenesis, neurogenesis and brain recovery of function following injury. Current Opinion in Investigational Drugs 2010, 11(3):298-308.
100. Yager J.Y., Thornhill J.A. The effect of age on susceptibility to hypoxic-ischemic brain damage. Neuroscience and Biobehavioral Reviews 1997, 21(2):167-174.
101. Yang S.E., Ha C.W., Jung M., Jin H.J., Lee M., Song H., Choi S., Oh W., Yang Y.S. Mesenchymal stem/progenitor cells developed in cultures from UC blood. Cytotherapy 2004, 6(5):476-486.
102. Yasuhara T., Hara K., Maki M., Xu L., Yu G., Ali M.M., Masuda T., Yu S.J., Bae E.K., Hayashi T., Matsukawa N., Kaneko Y., Kuzmin-Nichols N., Ellovitch S., Cruz E.L., Klasko S.K., Sanberg C.D., Sanberg P.R., Borlongan C.V. Mannitol facilitates neurotrophic factor upregulation and behavioral recovery in neonatal hypoxic-ischemic rats with human umbilical cord blood grafts. Journal of Cellular and Molecular Medicine 2010, 14(4):914-921.
103. Yenari M.A., Hemmen T.M. Therapeutic hypothermia for brain ischemia: where have we come and where do we go?. Stroke: A Journal of Cerebral Circulation 2010, 41(10 Suppl.):S72-74.
104. Yiu G., He Z. Glial inhibition of CNS axon regeneration. Nature Reviews 2006, 7(8):617-627.
105. Yoo K.H., Jang I.K., Lee M.W., Kim H.E., Yang M.S., Eom Y., Lee J.E., Kim Y.J., Yang S.K., Jung H.L., Sung K.W., Kim C.W., Koo H.H. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cellular Immunology 2009.
106. Zaibak F., Kozlovski J., Vadolas J., Sarsero J.P., Williamson R., Howden S.E. Integration of functional bacterial artificial chromosomes into human cord blood-derived multipotent stem cells. Gene Therapy 2009, 16(3):404-414.
107. Zawadzka M., Lukasiuk K., Machaj E.K., Pojda Z., Kaminska B. Lack of migration and neurological benefits after infusion of umbilical cord blood cells in ischemic brain injury. Acta Neurobiologiae Experimentalis 2009, 69(1):46-51.
108. Zhang R.L., Chopp M., Chen H., Garcia J.H. Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat. Journal of the Neurological Sciences 1994, 125(1):3-10.
109. Zhao Y., Wang H., Mazzone T. Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics. Experimental Cell Research 2006, 312(13):2454-2464.
110. Zhong X.Y., Zhang B., Asadollahi R., Low S.H., Holzgreve W. Umbilical cord blood stem cells: what to expect. Annals of the New York Academy of Sciences 2010, 1205:17-22.
111. Zigova T., Song S., Willing A.E., Hudson J.E., Newman M.B., Saporta S., Sanchez-Ramos J., Sanberg P.R. Human umbilical cord blood cells express neural antigens after transplantation into the developing rat brain. Cell Transplantation 2002, 11(3):265-274.